ArticlePharmaceuticals (Basel, Switzerland)2025

Emodin Enhances Rosiglitazone's Therapeutic Profile by Dual Modulation of SREBP1-Mediated Adipogenesis and PPARγ-Driven Thermogenesis.

Meng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.